Scientific and clinical progress together with the development of effective novel therapeutic
options has engendered multiple important changes in the diagnosis and management of …

This is an update to the 2014 Canadian Hereditary Angioedema Guideline with an
expanded scope to include the management of hereditary angioedema (HAE) patients …

Hereditary Angioedema (HAE) is a rare and disabling disease for which early diagnosis and
effective therapy are critical. This revision and update of the global WAO/EAACI guideline on …

Abstract Background We published the Canadian 2003 International Consensus Algorithm
for the Diagnosis, Therapy, and Management of Hereditary Angioedema (HAE; C1 inhibitor …

Hereditary Angioedema (HAE) is a rare disease and for this reason proper diagnosis and
appropriate therapy are often unknown or not available for physicians and other health care …

Hereditary angio-oedema is caused by a heterozygous deficiency of C1 inhibitor. This
inhibitor regulates several inflammatory pathways, and patients with hereditary angio …

To cite this article: Cicardi M, Bork K, Caballero T, Craig T, Li HH, Longhurst H, Reshef A,
Zuraw B on behalf of HAWK (Hereditary Angioedema International Working Group) …

Hereditary angioedema (HAE) is a rare but potentially life-threatening disease marked by
spontaneous, recurrent attacks of swelling. The broad range of consequences of HAE on …

These parameters were developed by the Joint Task Force on Practice Parameters (JTFPP),
representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the …

Hereditary angioedema (C1 inhibitor deficiency, HAE) is associated with intermittent
swellings which are disabling and may be fatal. Effective treatments are available and these …